Trivaris Approval History
FDA Approved: Yes (Discontinued) (First approved June 16, 2008)
Brand name: Trivaris
Generic name: triamcinolone acetonide
Dosage form: Intravitreal Injection
Company: Allergan plc
Treatment for: Ocular Inflammatory Conditions
Marketing Status: Discontinued
Trivaris (triamcinolone acetonide) is a glucocorticoid corticosteroid delivered via intravitreal injection for the treatment of sympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory conditions unresponsive to topical corticosteroids.
Development History and FDA Approval Process for Trivaris
|Jun 17, 2008||Allergan Receives U.S. Food and Drug Administration Approval for Trivaris (triamcinolone acetonide injectable suspension) 80 mg/mL|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.